Global Home Healthcare Market Overview
The Home Healthcare Market Size was valued at USD 268.86 Billion in 2023.
The Global Home Healthcare industry is projected to grow from USD 293.21 Billion in 2024 to USD 542.67 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.08% during the forecast period (2024 - 2032).
The market trends have been witnessing a rapid degree of growth in the elderly population and the rising incidence of chronic diseases. This is an undeniable fact that is growing the need for cost-effective healthcare delivery due to the increase in healthcare costs, and technological advancements regarding the availability of home care devices.
GE Healthcare, a division of General Electric valued at USD 17.7 billion, is increasing its efforts in home-based care by collaborating with AMC Health to offer remote patient monitoring (RPM). GE Healthcare and RPM have formed a cooperation to offer remote patient monitoring (RPM) as a virtual care option in patients' homes, rather than in a hospital. The alliance aims to optimize post-discharge surveillance for patients and provide doctors with the necessary data to enhance patient care.
Magellan Health Services and DUOS, a company specializing in senior care, have made the decision to broaden their partnership. Magellan has declared that its upcoming Senior Assistance service, fueled by DUOS, would be operational starting in October 2022. Magellan's latest offering involves matching its clients with individual aides, known as "Duos," who attend to their social needs and assist them in maintaining a high level of independence while aging in their own homes. Collectively, they will facilitate the ability of health plan members to utilize a broader array of community resources, so enabling the provision of more personalized and all-encompassing therapy within the confines of their own residence. Consumers have the option to directly contact the firm, which also collaborates with healthcare providers and third-party payers.
Take, for example, Simple HealthKit, which declared its at-home diagnostics and follow-up care kits for Diabetes (HbA1c), Respiratory Wellness, and Sexual Wellness in April 2024. Amazon sells the only kits that cover Influenza A, Influenza B and Respiratory Syncytial Virus (RSV), among other viruses, in their stores.
Similarly, Extendicare Inc. acquired Revera and its affiliates in August 2023, allowing them to acquire a 15% managed shares of 25 LTC homes owned by Revera and oversee an additional 31 LTC homes held by Revera.
In June 2023, Amedisys reached an agreement with Optum, which is a health services provider with diverse offerings. For example, Amedisys provides home health services like personalized home health care as well as hospice care while making over 11.2 million visits to patient’s homes each year.
In May 2023, Medtronic announced that it had signed an agreement to buy EOFlow Co. Ltd., the maker of EOPatch tubeless wearable fully disposable insulin delivery device.
Home Instead, Inc., in partnership with Meals on Wheels America, planned this awareness campaign through fundraising activities as well as volunteer recruitment programs. The intention behind this collaboration was not only to support elderly community members but also to address their healthcare concerns.
Regarding this acquisition of nightingales’ home health service by Health Care At Home Pvt Ltd (HCAH), it operates specialty home healthcare services, among others.
Koninklijke Philips N.V. introduced the Philips Virtual Care Management solutions portfolio in March 2023 as part of their telehealth approach to patient engagement improvement and better health outcomes.
OMRON Healthcare added new educational components into the OMRON Connect mobile application during February 2023, including such things as articles on study summaries & AFib identification alongside pointers for behavior change plus lifestyle modifications reducing risks of heart attack and stroke.
In March 2022, Blessing Health System in Quincy, Illinois selected Biofourmis as its technology solutions partner for their newest program designed to deliver acute hospital care to patient’s homes.
Home Healthcare Market Trends
- The rising aging population & nuclear homes will boost the market growth
The Home Healthcare market is expected to grow significantly, driven by the rising aging population and the trend toward nuclear homes. The aging population is increasingly choosing to age in place, rather than moving into assisted living facilities or nursing homes. This is largely due to the high cost of long-term care, as well as the desire to maintain independence and autonomy. Nuclear homes, or homes where all adults are employed and there are no children, are also on the rise. These families often have less time to care for elderly or disabled family members, so they are more likely to seek out professional home healthcare services.
Home Healthcare Market Segment Insights
Home Healthcare Product Insights
The market segmentation, based on Product, includes Testing, Screening and Monitoring Products, Blood Glucose Monitors, Blood Pressure Monitors, Pulse Oximeters, Peak Flow Meters, Heart Rate Monitors, Fetal Monitoring Devices, HIV Test Kits, Home Sleep Testing Devices, Others. The Blood Pressure Monitors segment held the majority share in the Home Healthcare revenue. This can be attributed to the growing awareness among consumers about the importance of monitoring their blood pressure at home. Additionally, the availability of advanced and technologically advanced blood pressure monitors at affordable prices has also contributed to the segment's growth.
Home Healthcare Service Insights
Based on Service, the market segmentation includes Skilled Nursing Services, Rehabilitation Therapy Services, Hospice, and Palliative Care Services, Unskilled Care Services, Respiratory Therapy Services, Infusion Therapy Services, and Others. The Skilled Nursing Services segment is projected to be the faster-growing segment during the forecast period, 2024-2032. The growth of this segment is driven by the increasing demand for skilled nursing services due to the aging population and the rising prevalence of chronic diseases.
Home Healthcare Indication Insights
Based on the Indication, the market segmentation includes Cardiovascular Disorders and Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Mobility Disorders, Hearing Disorders, Cancer, Wound Care, Other. The Cardiovascular Disorders and Hypertension segment dominated the market in 2021. The segment's growth is driven by the increasing prevalence of cardiovascular diseases and the growing awareness of the benefits of home healthcare.
Figure 2: Home Healthcare Market, by Indication, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Home Healthcare Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region is predicted to hold the first position in the market for home healthcare owing to the rising demand for home healthcare and an increase in the number of clinics and hospitals that are providing treatment for home healthcare. In America, the North American market is the largest market owing to the presence of the key market players in the market that provide both products and instruments for home healthcare.
Figure 3: HOME HEALTHCARE MARKET SHARE BY REGION 2023 (%)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe region accounts for the second-largest Home Healthcare market share. This is because European counties normally have a high population with an increasingly aging population. This is influencing the demand for Home Healthcare products and services in the industry.
Asia-Pacific is estimated to rise at the fastest CAGR of the market due to the increasing number of incidences of chronic diseases, increasing demand for effective healthcare remedies, technological advancement in the healthcare industry, and geographical expansion of the Home Healthcare market.
Home Healthcare Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the market grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Home Healthcare industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
Manufacturing locally to cut operating costs is one of the main business tactics manufacturers use in the Home Healthcare industry to benefit customers and expand the market sector. The market has recently given medicine some of the most important advantages. Major hair care product market players, including Abbott, GE Healthcare, Axxess, CVS Pharmacy, and Becton Dickinson Company, are attempting to increase Home Healthcare market demand by funding R&D initiatives.
Abbott Laboratories is a medical device firm that develops, produces, and distributes medical devices. The firm sells diagnostics, medical equipment, nutritional supplements, and branded generic pharmaceuticals. It provides gastroenterology, women's health, cardiovascular and metabolic, pain and central nervous system products, respiratory drugs and vaccines, core laboratory systems, molecular diagnostics polymerase chain reaction (PCR) instrument systems, rapid diagnostics lateral flow testing products, point of care systems, and informatics and automation solutions, various forms of infant formula and follow-on formula, adult and other pediatric nutritional products, and informatics and automation solutions.
Also, GE Healthcare, which was formed in 1892, is a provider of medical technology and digital solutions. It provides goods and services such as anesthetic administration, contrast media, computed tomography, bone, and metabolic health, interoperability, molecular imaging, patient monitoring, surgical imaging, invasive cardiology, and others. Interventional image-guided systems, fluoroscopy equipment, accessories and supplies, ventilators, digital solutions, and clinical network solutions are also available from the firm.
Key Companies in the Home Healthcare market include
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche AG
- A&D Company
- Fresenius SE & Co KGaA
- Abbott
- GE Healthcare
- Axxess
- CVS Pharmacy
- Becton Dickinson Company
- Omron Corporation
- Medtronic PLC
- LG Electronics
- Kinnser Software
- Apple
- 3M
Home Healthcare Industry Developments
In March 2022: Axxess launched a fully independent palliative care software solution. Axxess Palliative Care is the latest innovation in Axxess' complete suite of solutions developed for organizations that provide care in the home.
In February 2022: CVS Pharmacy launched six home healthcare products as an extension of the company's CVS Health product line. The new products include convertible shower chairs, easy-fold travel walkers, and canes with comfort grips.
Home Healthcare Market Segmentation
Home Healthcare Product Outlook
- Testing, Screening and Monitoring Products
- Blood Glucose Monitors
- Blood Pressure Monitors
- Pulse Oximeters
- Peak Flow Meters
- Heart Rate Monitors
- Fetal Monitoring Devices
- HIV Test Kits
- Home Sleep Testing Devices
- Others
Home Healthcare Service Outlook
- Skilled Nursing Services
- Rehabilitation Therapy Services
- Hospice and Palliative Care Services
- Unskilled Care Services
- Respiratory Therapy Services
- Infusion Therapy Services
- Others
Home Healthcare Indication Outlook
- Cardiovascular Disorders and Hypertension
- Diabetes
- Respiratory Diseases
- Pregnancy
- Mobility Disorders
- Hearing Disorders
- Cancer
- Wound Care
- Other
Home Healthcare Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 268.86 Billion |
Market Size 2024 |
USD 293.21 Billion |
Market Size 2032 |
USD 542.67 Billion |
Compound Annual Growth Rate (CAGR) |
7.08% (2024-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2018 & 2020 |
Market Forecast Units |
Value (USD Million) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Product, Service, Indication, and Region |
Geographies Covered |
North America, Europe, Asia-Pacific, and the Rest of the World |
Countries Covered |
The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
Koninklijke Philips, F. Hoffmann-La Roche, A&D Company, Fresenius SE & Co, Abbott, GE Healthcare, Axxess, CVS Pharmacy, Becton Dickinson Company, Omron Corporation, Medtronic, LG Electronics, Kinnser Software, Apple, 3M |
Key Market Opportunities |
Technological Advancement |
Key Market Dynamics |
Rising aging population |
Home Healthcare Market Highlights:
Frequently Asked Questions (FAQ) :
The Home Healthcare market size was valued at USD 268.86 Billion in 2023.
The market is projected to grow at a CAGR of 7.08% during the forecast period, 2024-2032.
North America had the largest share of the Home Healthcare market.
The key players in the market are Koninklijke Philips, F. Hoffmann-La Roche, A&D Company, Fresenius SE & Co, Abbott, GE Healthcare, Axxess, CVS Pharmacy, Becton Dickinson Company, Omron Corporation, Medtronic, LG Electronics, Kinnser Software, Apple, 3M.
The Blood Pressure Monitors category dominated the market in 2023.
Cardiovascular Disorders and Hypertension had the largest share in the market for Home Healthcare.